GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (NYSE:PRGO) » Definitions » Shiller PE Ratio
中文

Perrigo Co (Perrigo Co) Shiller PE Ratio : (As of Apr. 25, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Perrigo Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Shiller PE Ratio Historical Data

The historical data trend for Perrigo Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Shiller PE Ratio Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Perrigo Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Perrigo Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Shiller PE Ratio falls into.



Perrigo Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Perrigo Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Perrigo Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.24/120.1096*120.1096
=-0.240

Current CPI (Dec. 2023) = 120.1096.

Perrigo Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.360 100.573 0.430
201406 1.340 100.773 1.597
201409 0.720 100.474 0.861
201412 0.510 99.576 0.615
201503 -0.670 99.975 -0.805
201506 0.380 100.573 0.454
201509 0.770 100.274 0.922
201512 -0.480 99.676 -0.578
201603 -2.340 99.676 -2.820
201606 -3.730 101.072 -4.433
201609 -11.100 100.274 -13.296
201612 -9.480 99.676 -11.423
201703 0.500 100.374 0.598
201706 -0.490 100.673 -0.585
201709 0.310 100.474 0.371
201712 0.510 100.075 0.612
201803 0.570 100.573 0.681
201806 0.260 101.072 0.309
201809 -0.490 101.371 -0.581
201812 0.590 100.773 0.703
201903 0.470 101.670 0.555
201906 0.070 102.168 0.082
201909 0.670 102.268 0.787
201912 -0.140 102.068 -0.165
202003 0.770 102.367 0.903
202006 0.440 101.769 0.519
202009 -1.130 101.072 -1.343
202012 -1.290 101.072 -1.533
202103 0.280 102.367 0.329
202106 -0.430 103.364 -0.500
202109 -0.440 104.859 -0.504
202112 0.070 106.653 0.079
202203 -0.020 109.245 -0.022
202206 -0.480 112.734 -0.511
202209 -0.370 113.431 -0.392
202212 -0.170 115.425 -0.177
202303 -0.020 117.618 -0.020
202306 0.060 119.611 0.060
202309 0.100 120.708 0.100
202312 -0.240 120.110 -0.240

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (NYSE:PRGO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Perrigo Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (Perrigo Co) Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Executives
Robert Willis officer: Acting CHRO C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Alison Ives officer: EVP & Chief Scientific Officer C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Eduardo Guarita Bezerra officer: EVP & Chief Financial Officer C/O FRESH DEL MONTE PRODUCE INC., PO BOX 149222, CORAL GABLES FL 33134
Patrick Lockwood-taylor director, officer: CEO C/O PERRIGO COMPANY PLC, 430 MONROE AVE NW, GRAND RAPIDS MI 49503
Julia M Brown director C/O ABLE BRANDS CO., 30 HUDSON YARDS, NEW YORK NY 10001
Triona Schmelter officer: EVP & President CSCA 2021 SPRING ROAD, SUITE 600, OAK BROOK IL 60523
Geoffrey M. Parker director 15 RIORDAN PLACE, MENLO PARK CA 94025
Svend Andersen director C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Murray S Kessler director, officer: CEO 714 GREEN VALLEY ROAD, GREENSBORO NC 27408
Thomas Farrington officer: Senior VP and CIO 4012 W. CANTERBURY CT., NEQUON WI 53092
Dillard James E Iii officer: EVP, Chief Scientific Officer 6601 WEST BROAD STREET, RICHMOND VA 23230
Ronald Craig Janish officer: EVP, Global Op. & Supply Chain PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Grainne Quinn officer: EVP, Chief Medical Officer PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Albert Manzone director C/O MERISANT, AVENUE JEAN-JACQUES ROUSSEAU 7, NEUCHATEL V8 CH-2000
Kyle Hanson officer: EVP & General Counsel